Table 2. Comparison of major clinical endpoints and medical adherence in two groups (36 months) – no. (%).

	Intensive follow-up (n = 337)	Usual follow-up (n = 332)	p-value
Good medication adherence	190 (56.4)	133 (40.1)	< 0.001
MACE
Recurrent angina	73 (21.7)	104 (31.3)	0.005
Nonfatal myocardial infarction	6 (1.8)	13 (3.9)	0.10
Coronary revascularization	10 (3.0)	24 (7.2)	0.01
Cardiovascular mortality	13 (3.9)	31 (9.3)	0.004
All-cause mortality	16 (4.7)	36 (10.8)	0.003
Bleeding
Minimal/minor	17 (5.0)	24 (7.2)	0.24
Major	8 (2.4)	12 (3.6)	0.35

MACE, major adverse cardiac events.